Stay updated on TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The MedlinePlus related topics section was shortened by removing the Melanoma and MedlinePlus Genetics entries, changing the set of related-topic links shown on the page.
    Difference
    0.1%
    Check dated 2026-07-17T09:46:59.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. This does not change displayed information or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-07-03T13:56:51.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.0 to v3.6.2, indicating a newer build of the page. It does not reflect any substantive changes to the study details.
    Difference
    0.0%
    Check dated 2026-06-26T18:11:24.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page gained several new navigation/help items aimed at prospective participants, including 'Check who can join', 'Find Contact Information', 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. A formatting change from 'Intervention / Treatment' to 'Intervention/Treatment' was made and a site revision stamp (Revision: v3.6.0) was added, along with related date markers.
    Difference
    0.7%
    Check dated 2026-06-12T16:48:46.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The revision version has been updated from v3.5.4 to v3.5.5, indicating a behind-the-scenes platform/template update.
    Difference
    0.0%
    Check dated 2026-06-05T20:30:32.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    New related topic navigation entries were added for Melanoma and MedlinePlus Genetics, expanding access to related informational resources on the page.
    Difference
    0.1%
    Check dated 2026-05-29T23:14:59.000Z thumbnail image

Stay in the know with updates to TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TILs Plus IL-2 Versus Pembrolizumab in Melanoma Clinical Trial page.